As of Sep 04
| +0.02 / +0.04%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 67.00, with a high estimate of 79.00 and a low estimate of 65.00. The median estimate represents a +29.37% increase from the last price of 51.79.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.